Advantages of HPLC with Ultra Stable Phases

具有超稳定相的 HPLC 的优点

• 批准号: 7940882
• 负责人: PETER W CARR
• 金额: $ 29.77万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 1996
• 资助国家: 美国
• 起止时间: 1996-08-01 至 2012-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7940882
• 关键词: Acids; Adsorption; Affinity Chromatography; Agriculture; Algorithms; Biocompatible Materials; Biological; Biological Markers; Carbohydrates; Cations; Chemicals; Chromatography; Coffee; Complex; Complex Mixtures; Computer software; Computers; Computing Methodologies; Data; Data Analyses; Data Set; Dependence; Detection; Development; Dimensions; Dimethyl Sulfoxide; Disease; Effectiveness; Excision; Food; Fractionation; Goals; High Pressure Liquid Chromatography; High temperature of physical object; Imagery; Liquid Chromatography; Maize; Measurement; Medical; Metabolism; Methods; Modeling; Molecular Weight; Peptides; Pharmacologic Substance; Phase; Plants; Problem Solving; Process; Proteomics; Relative (related person); Resolution; Route; Running; Sampling; Scientist; Series; Solutions; Solvents; Speed; System; Techniques; Theoretical Studies; Time; Training; Urine; Variant; Viscosity; Wine; Work; Workplace; base; crosslink; design; detector; improved; innovation; instrument; instrumentation; interest; metabolomics; mutant; novel; operation; particle; public health relevance; research study; solute; toxicant; two-dimensional

DESCRIPTION (provided by applicant): The present proposal assembles a team of separation scientists, analytical chemists and 2 computer scientists to further develop high speed two-dimensional liquid chromatography 3 (2DLC). Our principal goal is to transform 2DLC from a niche technique for use on complex 4 samples with 1000s of components into a more practical, accessible method. We will make and 5 characterize a number of innovative stable stationary phases, including a weak acid cation 6 exchanger that we believe will be ideally suited for mass spec analysis as well as novel, 7 zwitterionic and very highly hydrophilic phases designed for use as RPLC and HILIC phases for 8 2DLC. After characterization, we will focus on high-speed, robust application of these materials 9 in biomedical studies and the analysis of pharmaceuticals and environmental and workplace 10 toxicants. Stable phases are critical for use as the ultra-fast second dimension column when we 11 use high temperature LC to implement high speed 2DLC. We now generate effective (not 12 hypothetical) peak capacities of well over 1,000 in a total time of 30 minutes, thereby reaching 13 rates of two peaks/second. In prior work, 2DLC was applied to a tryptic digest (IEX x RPLC), the 14 low molecular weight components of native and mutant maize extracts, as well as urine, wine and 15 coffee samples, all using RPLC x RPLC. More important, the limitations of 2DLC were studied 16 and a systematic comparison to fully optimized 1DLC was initiated. We showed that 2DLC 17 produces more resolution than fully optimized 1DLC in times of only about 10 minutes. Our 18 work shows that it will be important to increase the speed of the second dimension even further. 19 Thus, by additional improvements in instrument and column design, we propose to increase the 20 speed of the second dimension without compromising peak capacity. Moreover, we will develop 21 a novel mode of separation-"dynamic gradient elution"-to maximize use of the 2D separation 22 space and thus peak capacity. We will explore the potential of unusual RPLC solvents and a 23 novel stationary phase for optimizing the first separation dimension. We propose the exploration 24 of chemically selective pre-fractionation methods to create a "pseudo" three-dimensional 25 separation. Initial efforts will focus on chemically selective methods of carbohydrate separation 26 and their application to glycomics. A series of theoretical studies aimed at understanding the 27 compromises involved in optimizing 2DLC separations will also be done. Finally, retention time 28 alignment in 2DLC is much more difficult and more serious than in 2DGC. We will approach this 29 problem by several new chemometric routes so that long-term metabolomic studies can be carried 30 out by 2DLC, which is clearly superior to 2DGC for biological materials. PUBLIC HEALTH RELEVANCE: The vast majority of all biological, medical, agricultural and environmental experiments and measurements involve the analysis of extremely complex mixtures containing hundreds, if not thousands, of different chemical entities spanning a million fold or greater range in relative amounts. The analysis of these mixtures only becomes possible when the chemicals of interest can be separated from all interfering substances. The object of this work is to improve the separating power, and especially the speed, of liquid chromatography to allow the detailed, high resolution study of complex biological mixtures and thus make it possible to find the biomarkers of disease as well as promote our understanding of the metabolism of foods and pharmaceuticals.

描述（由申请人提供）：本提案集合了一个由分离科学家、分析化学家和2名计算机科学家组成的团队，以进一步开发高速二维液相色谱3（2DLC）。我们的主要目标是将2DLC从用于复杂4个样品的利基技术转变为更实用，更容易获得的方法。我们将制造和表征一些创新的稳定固定相，包括我们认为将非常适合质谱分析的弱酸阳离子交换剂，以及设计用作RPLC和HILIC相的新型两性离子和高度亲水相。在表征之后，我们将专注于这些材料在生物医学研究中的高速，稳健的应用，以及药物和环境和工作场所有毒物质的分析。当我们使用高温LC来实现高速2DLC时，稳定相对于用作超快第二维柱是关键的。我们现在在30分钟的总时间内产生远远超过1,000的有效（而不是12个假设的）峰值容量，从而达到13个每秒两个峰值的速率。在先前的工作中，2DLC应用于胰蛋白酶消化物（IEX x RPLC），天然和突变玉米提取物的14种低分子量组分，以及尿液，葡萄酒和15种咖啡样品，所有这些都使用RPLC x RPLC。更重要的是，研究了2DLC的局限性16，并开始与完全优化的1DLC进行系统比较。我们发现，2DLC 17比完全优化的1DLC在大约10分钟的时间内产生更高的分辨率。我们的工作表明，进一步提高第二维的速度将是重要的。因此，通过仪器和柱设计的额外改进，我们建议在不损害峰值容量的情况下增加第二维的速度。此外，我们将开发21一种新的分离模式-“动态梯度洗脱”-以最大限度地利用2D分离22空间，从而达到峰值容量。我们将探索不寻常的RPLC溶剂和23种新型固定相的潜力，以优化第一分离尺寸。我们建议探索化学选择性预分级方法以产生“伪”三维分离。最初的努力将集中在碳水化合物分离的化学选择性方法26及其在糖组学中的应用。还将进行一系列旨在了解优化2DLC分离所涉及的27个折衷方案的理论研究。最后，2DLC中的保留时间28比对比2DGC中困难得多且更严重。我们将通过几种新的化学计量学途径来解决这个问题，以便通过2DLC进行长期的代谢组学研究，这显然上级生物材料的2DGC。公共卫生关系：绝大多数生物、医学、农业和环境实验和测量都涉及分析极其复杂的混合物，这些混合物含有数百种（如果不是数千种）不同的化学实体，其相对量跨越百万倍或更大的范围。只有当感兴趣的化学品可以从所有干扰物质中分离出来时，才能对这些混合物进行分析。这项工作的目的是提高液相色谱的分离能力，特别是速度，以便对复杂的生物混合物进行详细的高分辨率研究，从而有可能找到疾病的生物标志物，并促进我们对食品和药物代谢的理解。